Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

129
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
129
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

158
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
158
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

71
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
71
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

239
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
239
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

17.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
17.0K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

119
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
119

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Construction and co-expression of a polycistronic plasmid encoding carbonyl reductase and glucose dehydrogenase for production of ethyl (S)-4-chloro-3-hydroxybutanoate.

Bioresource technology·2010
Same author

Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized trial.

World journal of urology·2010
Same author

Validation, In-Depth Analysis, and Modification of the Micropipette Aspiration Technique.

Cellular and molecular bioengineering·2010
Same author

High-level production of heterologous proteins using untreated cane molasses and corn steep liquor in Escherichia coli medium.

Applied microbiology and biotechnology·2010
Same author

[Application of in situ cryogenic Raman spectroscopy to analysis of fluid inclusions in reservoirs].

Guang pu xue yu guang pu fen xi = Guang pu·2010
Same author

Effect of genetic deletion of the vanilloid receptor TRPV1 on the expression of Substance P in sensory neurons of mice with adjuvant-induced arthritis.

Neuropeptides·2010
Same journal

Axial gout diagnosed by dual-energy CT in a young normouricaemic man with recurrent nephrolithiasis: a case-based review.

Rheumatology international·2026
Same journal

Psoriatic arthritis patients have increased morbidity already at the time of diagnosis: a case-control study.

Rheumatology international·2026
Same journal

VEXAS syndrome unmasked from relapsing polychondritis and infection mimicry: a case-based review.

Rheumatology international·2026
Same journal

Myocarditis as the first sign of SLE: a case report and review of the literature.

Rheumatology international·2026
Same journal

Infrared thermography of the tongue in systemic lupus erythematosus: a pilot study of thermal response to cold stimulation.

Rheumatology international·2026
Same journal

Pre-referral laboratory completeness and diagnostic yield in an early arthritis clinic: a retrospective single-centre analysis.

Rheumatology international·2026
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.6K

Correlation between P2X7 receptor gene polymorphisms and gout.

Qiong-Yao Gong1, Yong Chen

  • 1Department of Rheumatology, Ningbo No.2 Hospital, Ningbo, Zhejiang, 315010, China.

Rheumatology International
|March 25, 2015
PubMed
Summary
This summary is machine-generated.

Genetic variations in the P2X7 receptor gene influence interleukin-1β secretion, affecting gout development. These P2X7R gene polymorphisms are crucial in understanding the pathogenesis of gouty arthritis.

More Related Videos

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Related Experiment Videos

Last Updated: Apr 15, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.6K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.4K

Area of Science:

  • Immunology
  • Genetics
  • Rheumatology

Background:

  • Hyperuricemia does not always lead to gout, suggesting other factors are involved.
  • The P2X7 receptor (P2X7R) is a key proinflammatory mediator involved in cytokine release.
  • Interleukin-1β (IL-1β) is central to acute inflammation and gout pathogenesis.

Purpose of the Study:

  • To review single-nucleotide polymorphisms (SNPs) in the P2X7R gene.
  • To investigate the correlation between P2X7R gene SNPs and gout incidence.
  • To elucidate the role of P2X7R in gout pathogenesis.

Main Methods:

  • Literature review of P2X7R gene polymorphisms.
  • Analysis of specific P2X7R SNPs: rs1718119, rs208294, rs3751143, rs28360457, rs2230911.
  • Correlation analysis between SNPs and gout incidence.

Main Results:

  • P2X7R gene polymorphisms are associated with varying IL-1β secretion levels.
  • Specific P2X7R SNPs may influence susceptibility to gout.
  • The P2X7R receptor's role in IL-1β processing is critical.

Conclusions:

  • P2X7R gene polymorphisms significantly impact IL-1β secretion.
  • These genetic variations play a vital role in the pathogenesis of gout.
  • Understanding P2X7R genetics is key to gout research.